BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32501471)

  • 41. Loss of disialyl Lewis(a), the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulin-like lectin-7 (Siglec-7) associated with increased sialyl Lewis(a) expression on human colon cancers.
    Miyazaki K; Ohmori K; Izawa M; Koike T; Kumamoto K; Furukawa K; Ando T; Kiso M; Yamaji T; Hashimoto Y; Suzuki A; Yoshida A; Takeuchi M; Kannagi R
    Cancer Res; 2004 Jul; 64(13):4498-505. PubMed ID: 15231659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.
    Hakomori S
    Adv Exp Med Biol; 2001; 491():369-402. PubMed ID: 14533809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening and Identification of a Novel Anti-Siglec-15 Human Antibody 3F1 and Relevant Antitumor Activity.
    Wu J; Peng J; Zhou Y; Zhang R; Wang Z; Hu N; Zhang D; Quan G; Wu Y; Feng J; Shen B; Zhao J; Zhang Y; Yang K; Luo L
    Mol Pharmacol; 2022 Sep; 102(3):161-171. PubMed ID: 35764384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor-associated Neu5Ac-Tn and Neu5Gc-Tn antigens bind to C-type lectin CLEC10A (CD301, MGL).
    Mortezai N; Behnken HN; Kurze AK; Ludewig P; Buck F; Meyer B; Wagener C
    Glycobiology; 2013 Jul; 23(7):844-52. PubMed ID: 23507963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A versatile soluble siglec scaffold for sensitive and quantitative detection of glycan ligands.
    Rodrigues E; Jung J; Park H; Loo C; Soukhtehzari S; Kitova EN; Mozaneh F; Daskhan G; Schmidt EN; Aghanya V; Sarkar S; Streith L; St Laurent CD; Nguyen L; Julien JP; West LJ; Williams KC; Klassen JS; Macauley MS
    Nat Commun; 2020 Oct; 11(1):5091. PubMed ID: 33037195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes.
    Varchetta S; Brunetta E; Roberto A; Mikulak J; Hudspeth KL; Mondelli MU; Mavilio D
    PLoS One; 2012; 7(9):e45821. PubMed ID: 23029261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sialic Acid-Siglec-E Interactions During
    Mukherjee K; Khatua B; Mandal C
    Front Immunol; 2020; 11():332. PubMed ID: 32184783
    [No Abstract]   [Full Text] [Related]  

  • 48. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sialic acid-binding immunoglobulin-like lectin (Sigelac)-15 is a rapidly internalised cell-surface antigen expressed by acute myeloid leukaemia cells.
    Cao H; Neerincx A; de Bono B; Lakner U; Huntington C; Elvin J; Gudgin E; Pridans C; Vickers MA; Huntly B; Trowsdale J; Barrow AD
    Br J Haematol; 2021 Jun; 193(5):946-950. PubMed ID: 33951750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E).
    Erdmann H; Steeg C; Koch-Nolte F; Fleischer B; Jacobs T
    Cell Microbiol; 2009 Nov; 11(11):1600-11. PubMed ID: 19552697
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sialyl-Tn Polysaccharide A1 as an Entirely Carbohydrate Immunogen: Synthesis and Immunological Evaluation.
    Shi M; Kleski KA; Trabbic KR; Bourgault JP; Andreana PR
    J Am Chem Soc; 2016 Nov; 138(43):14264-14272. PubMed ID: 27726393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9.
    Rodriguez E; Boelaars K; Brown K; Eveline Li RJ; Kruijssen L; Bruijns SCM; van Ee T; Schetters STT; Crommentuijn MHW; van der Horst JC; van Grieken NCT; van Vliet SJ; Kazemier G; Giovannetti E; Garcia-Vallejo JJ; van Kooyk Y
    Nat Commun; 2021 Feb; 12(1):1270. PubMed ID: 33627655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity.
    Prendergast JM; Galvao da Silva AP; Eavarone DA; Ghaderi D; Zhang M; Brady D; Wicks J; DeSander J; Behrens J; Rueda BR
    MAbs; 2017; 9(4):615-627. PubMed ID: 28281872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The human sialic acid-binding immunoglobulin-like lectin Siglec-9 and its murine homolog Siglec-E control osteoclast activity and bone resorption.
    Andes FT; Adam S; Hahn M; Aust O; Frey S; Grueneboom A; Nitschke L; Schett G; Steffen U
    Bone; 2021 Feb; 143():115665. PubMed ID: 33007530
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5.
    Pegon JN; Kurdi M; Casari C; Odouard S; Denis CV; Christophe OD; Lenting PJ
    Haematologica; 2012 Dec; 97(12):1855-63. PubMed ID: 22733016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
    Roy S; Mandal C
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural basis for sulfation-dependent self-glycan recognition by the human immune-inhibitory receptor Siglec-8.
    Pröpster JM; Yang F; Rabbani S; Ernst B; Allain FH; Schubert M
    Proc Natl Acad Sci U S A; 2016 Jul; 113(29):E4170-9. PubMed ID: 27357658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake.
    Jones C; Virji M; Crocker PR
    Mol Microbiol; 2003 Sep; 49(5):1213-25. PubMed ID: 12940982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunopositivity for Siglec-15 in gastric cancer and its association with clinical and pathological parameters.
    Quirino MWL; Pereira MC; Deodato de Souza MF; Pitta IDR; Da Silva Filho AF; Albuquerque MSS; Albuquerque APB; Martins MR; Pitta MGDR; Rêgo MJBM
    Eur J Histochem; 2021 Mar; 65(1):. PubMed ID: 33666065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.